Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:insulin
|
| gptkbp:administeredOnceDaily |
true
|
| gptkbp:alternativeTo |
gptkb:Basaglar
gptkb:Semglee |
| gptkbp:approvalYear |
2000
|
| gptkbp:ATCCode |
A10AE04
|
| gptkbp:biosimilar |
true
|
| gptkbp:brand |
gptkb:insulin
|
| gptkbp:CASNumber |
160337-95-1
|
| gptkbp:chemicalFormula |
C267H404N72O78S6
|
| gptkbp:duration |
up to 24 hours
|
| gptkbp:form |
solution for injection
|
| gptkbp:halfLife |
about 24 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lantus
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Sanofi
|
| gptkbp:marketedAs |
gptkb:Germany
|
| gptkbp:mechanismOfAction |
long-acting insulin analog
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
gptkb:hypoglycemia
injection site reaction weight gain |
| gptkbp:status |
FDA approved
|
| gptkbp:storage |
2–8°C (refrigerated)
|
| gptkbp:usedFor |
gptkb:diabetes_mellitus_type_2
diabetes mellitus type 1 |
| gptkbp:bfsParent |
gptkb:Sanofi
|
| gptkbp:bfsLayer |
5
|